Aroa Biosurgery Ltd (arx) Logo

Aroa Biosurgery Ltd (ARX)

___:___ · Healthcare
ASX Delayed
Cboe Live

What is live streaming pricing?

Stock prices will auto-update without reloading the page. How it works:

  • Flashing prices signify an increase (green) or decrease (red) from previous price. Otherwise, price is unchanged.
  • Expect a short delay while pricing data initially loads.
  • Note, prices only update during market hours (10am-4:13pm AEST).

More about Cboe Live pricing.

OK, got it
0.00
0.00
(0.00)
VOLUME
DIV YIELD
PE RATIO
1 YR RETURN
52 WEEK RANGE
Overview
Financials
News

ARX ASX Chart

Snapshot

Aroa Biosurgery is a soft-tissue regeneration company committed to 'unlocking regenerative healing for everybody'. We develop, manufacture, sell and distribute medical and surgical products to improve healing in complex wounds and soft tissue reconstruction. The products are developed from a proprietary AROA ECM technology platform, a novel extracellular matrix biomaterial derived from ovine (sheep) forestomach.

Share Price Activity (ASX)

Last (Price)
Change 0.00 (0.00)
Bid / Ask -
Volume
Volume (4w avg)
Turnover
Open
Day Range -
VWAP
Prev Close
Last Trade

Performance

1 Week
1 Month
2024 YTD
1 Year
vs Sector (1yr) -56.51%
vs ASX 200 (1yr) -52.83%

Size

Market Cap Question Mark Icon
Excludes mandatory escrowed shares and foreign shares.
ASX Rank 760 of 2,360
Sector Rank 55 of 226

Key Fundamentals

Shares Issued
Sector Healthcare
Similar Companies SDI / SOM / AVR
EPS -$0.028
DPS $0.00
Book Value Per Share $0.20

Broker Consensus

ARX is not covered by a major broker, or data from most recent compilation was omitted due to not meeting QA guidelines.

Announcements

Price Sensitive only

Corporate Overview

Corporate Details

Head Office Mangere Auckland New Zealand 2022
Website www.aroabio.com
Registry BoardRoom
Auditor BDO Auckland
Date Listed 24 Jul 2020

Upcoming Calendar (Forecasted)

Date Event
26/11/2024 Report (Interim)
20/05/2025 Report (Prelim)
23/06/2025 Report (Annual)

Former Company Names

  • Aroa Biosurgery Ltd has no former company names.

Dividend History

DPS and Yield calculations use the Pay Date.

Ex-Date Amount Franking Gross Type Payable
No dividends paid.

See Upcoming Dividends for all ASX companies.

Directors & Management

Directors

Management

Director Transactions

ARX directors must report any change in shareholding to the ASX within 5 business days.

See Director Transactions for all ASX companies.

Date Director Type Amount Price Value Notes
22/08/24 Darla Hutton Issued 140,110 $1.00 $140,110 Issue of securities
22/08/24 Brian Ward Issued 961,255 $0.44 $422,952 Issue of securities
27/03/24 Steven (Steve) Engle Issued 633,225 $0.098 $61,992 Exercise of options
27/03/24 Steven (Steve) Engle Exercise 633,225 $0.098 $61,992 Exercise of options
16/02/24 Philip McCaw Buy +326,000 $0.575 $187,450 On-market trade
06/09/23 James (Jim) McLean Buy +50,000 $0.75 $37,500 Exercise of options
06/09/23 James (Jim) McLean Exercise 50,000 $0.75 $37,500 Exercise of options
11/08/23 Catherine Mohr Issued 210,686 $0.88 $185,403 Issue of options
31/03/23 Steven (Steve) Engle Issued 172,620 $1.05 $181,251 Issue of options
31/03/23 John Pinion II Issued 172,620 $1.05 $181,251 Issue of options
31/03/23 James (Jim) McLean Issued 258,929 $1.05 $271,875 Issue of options
31/03/23 Brian Ward Issued 2,575,483 $1.05 $2,704,257 Issue of options
31/03/23 Philip McCaw Issued 172,620 $1.05 $181,251 Issue of options
31/03/23 John Diddams Issued 172,620 $1.05 $181,251 Issue of options
14/12/22 John Diddams Issued 20,452 $1.09 $22,292 Issue of options
14/12/22 John Diddams Buy +165,000 $0.107 $17,732 Exercise of options
14/12/22 John Diddams Exercise 165,000 $0.107 $17,732 Exercise of options
30/08/22 John Diddams Buy +50,000 $0.806 $40,286 On-market trade
12/04/22 James (Jim) McLean Buy +102,400 $0.75 $76,800 Exercise of options
12/04/22 James (Jim) McLean Exercise 102,400 $0.75 $76,800 Exercise of options
12/04/22 Philip McCaw Buy +81,925 $0.75 $61,443 Exercise of options
12/04/22 Philip McCaw Exercise 81,925 $0.75 $61,443 Exercise of options
25/03/22 John Diddams Buy +165,000 $0.107 $17,732 Exercise of options
25/03/22 John Diddams Exercise 165,000 $0.107 $17,732 Exercise of options
19/08/21 James (Jim) McLean Buy +102,400 $0.75 $76,800 Exercise of options
19/08/21 James (Jim) McLean Exercise 102,400 $0.75 $76,800 Exercise of options
06/08/21 Philip McCaw Transfer 2,864,879 $1.15 $3,298,621 Off-market transfer
11/06/21 Philip McCaw Buy +81,925 $0.75 $61,443 Exercise of options
11/06/21 Philip McCaw Exercise 81,925 $0.75 $61,443 Exercise of options
22/02/21 John Diddams Sell +200,000 $1.19 ($238,680) On-market trade
09/12/20 John Diddams Buy +165,000 $0.107 $17,737 Exercise of options
09/12/20 John Diddams Exercise 165,000 $0.107 $17,737 Exercise of options
Show All

Director Interests

The current holdings of ARX directors.

Director Last Notice Direct Shares Indirect Shares Options Convertibles
Darla Hutton 22/08/2024 140,110 N/A N/A N/A
Catherine Mohr 31/03/2024 N/A N/A 210,686 N/A
Brian Ward 31/03/2024 N/A N/A 5,708,008 N/A
John Pinion II 31/03/2024 N/A N/A 1,051,620 N/A
James (Jim) McLean 31/03/2024 N/A N/A 311,329 N/A
Philip McCaw 31/03/2024 N/A N/A 254,545 N/A
John Diddams 31/03/2024 N/A N/A 193,072 N/A

Shareholder Info

Top 20 Shareholders
About the Data

Data supplied by Morningstar and accurate on May 31, 2024.

It's not possible to publish a real-time Top 20 Shareholder list. Companies are not obliged to report this data (with the exception of Substantial Shareholders above 5%). If a company chooses to publish the data, it's usually once a year in their Annual Report.

All data is manually compiled so there might be a delay between the Annual Report being published and the data appearing on Market Index (<7 days for ASX 300 and up to 30 days for micro-caps).

Name Shares Capital
J P Morgan Nominees Australia Pty Limited 48,251,491 14.01%
Mr Brian Ward & Mrs Tracey Ward <Arawai No 2 A/C> 33,125,800 9.62%
HSBC Custody Nominees (Australia) Limited 32,670,040 9.49%
Citicorp Nominees Pty Limited 32,037,722 9.30%
Phil Mccaw <Mcsyth Capital Invest A/C> 19,597,251 5.69%
Richard Abbott <Jester 002 Investment A/C> 13,043,020 3.78%
BNP Paribas Noms (Nz) Ltd 10,520,679 3.05%
Aspire Nz Seed Fund Ltd 10,421,614 3.02%
National Nominees Limited 8,010,852 2.32%
K One W One (No 3) Ltd 5,882,550 1.70%
Custodial Services Limited <Beneficiaries Holding A/C> 4,532,679 1.31%
Sharon Bryant <Ot Investment A/C> 4,372,267 1.27%
HSBC Custody Nominees (Australia) Limited A/C 2 4,138,307 1.20%
Mr John Anthony Dell 3,508,864 1.01%
Bnp Paribas Noms Pty Ltd 3,387,642 0.98%
UBS Nominees Pty Ltd 3,336,270 0.96%
Barnaby May 3,272,775 0.95%
Christopher David Astley Milne 3,213,022 0.93%
K One W One Ltd 3,041,226 0.88%
James Mclean 2,827,108 0.82%

Shareholder Distribution

As reported in the most recent Annual Report.

Holding Size 1 - 1,000 1,001 - 5,000 5,001 - 10,000 10,001 - 100,000 100,001+ Total
No. of Shareholders 875 1,230 587 873 139 3,704

Substantial Shareholders

A substantial shareholder is a person or entity that owns 5% or more of the voting shares in a company. Shares can be held through multiple entities, so the Substantial Shareholders list differs from the Top 20 Shareholders list.

Shareholding changes less than 1% do not require notification to the market. When all “Last Notice” dates are identical, it suggests that no (or minimal) change has occurred since the most recent Annual Report.

Note: If a substantial shareholder's stake drops below 5%, the "Shareholders Selling" field shows full ownership as sold and sets "New %" to zero, even if they continue to hold shares under the limit.

Name Last Notice Total Shares Shares Held (%)
J P Morgan Nominees Australia Pty Limited 31/05/2024 48,251,491 14.01
Citicorp Nominees Pty Limited 31/05/2024 32,037,722 9.30
Phil McCaw 31/05/2024 19,597,251 5.69
HSBC Custody Nominees (Australia) Limited 31/05/2024 32,670,040 9.49
Brian Ward 31/05/2024 33,125,800 9.62
FirstCape Group Limited 23/08/2024 30,421,199 8.82
Acorn Capital Limited 23/08/2024 22,491,106 6.52

Shareholders Buying

12 month transaction history compiled from ASX announcements.

Date Name Bought Previous % New %
23-08-24 Acorn Capital Limited 5,212,470 5.02 6.52
23-08-24 FirstCape Group Limited 5,526,705 7.23 8.82
08-05-24 Acorn Capital Limited 17,278,636 -- 5.02
30-04-24 FirstCape Group Limited 24,894,494 -- 7.23
19-02-24 Harbour Asset Management Limited 3,480,624 5.25 6.25

Shareholders Selling

12 month transaction history compiled from ASX announcements.

No sell transactions reported by Substantial Shareholders in the past 12 months.

Historical Data

Share Price History

Date Close Change %Chg Open High Low Volume Turnover

Historical Data

Year Closing Price Last Trade
2024 $0.598 28 June
2023 $0.925 30 June
2022 $0.66 30 June
2021 $1.12 30 June
2018 $0.30 29 June
2017 $0.515 28 June
2016 $0.45 28 June
2015 $0.001 30 June
2014 $0.003 30 June
ARX Historical Price Data (CSV)
Up to 20 years of EOD share price history

Important note:

All year-end and CSV data is "as traded on the day" and ignores corporate actions (e.g. share splits)

Market Index, ASX and Morningstar Logos

All data on this page is supplied by the ASX, Morningstar and Market Index. Read the disclaimer.